ÂÜÀòÂÒÂ×

Datuk Phang Ah Tong

Director at Apex Healthcare

Datuk Phang Ah Tong was elected as an Independent Non-Executive Director of the Company on 24th May 2018. He was appointed as Chairman of the Remuneration Committee and a member of the Audit Committee and ceased from office as a member of the Nomination Committee on 23rd May 2019. He graduated with a Bachelor of Economics (Honours) from University of Malaya in 1981. He has had a distinguished career in the civil service of Malaysia, spanning 36 years in promoting foreign and domestic investments and assisted in developing the manufacturing and services sectors in Malaysia under the Malaysian Investment Development Authority ('MIDA') where his last held position was the Deputy Chief Executive Officer before his retirement in 2017. He has served in various capacity including being the Assistant Trade Commissioner for MIDA London and Director of MIDA New York. Upon returning to the MIDA headquarters, he was appointed the Director of Foreign Direct Investment ('FDI'), overseeing the promotion of global FDI into Malaysia. He is the Non-Executive Chairman of JF Technology Berhad and Jerasia Capital Berhad and an Independent Director of Inari Amertron Berhad and United Overseas Bank (Malaysia) Berhad. He is also the Chairman of Malaysia Automotive, Robotics and IoT Institute ('MARii'), an agency under the Ministry of International Trade and Industry ('MITI') and a Commission Member of the Malaysian Communications and Multimedia Commission ('MCMC'), a government agency under the Ministry of Communications and Multimedia.

He does not have any family relationship with any director and/or major shareholder of the Group, or any personal interest in any business arrangement involving the Company. He attended all of the four Board Meetings held in the financial year ended 31st December 2020 and has had no convictions for any offences within the past 5 years, other than traffic offences, if any and has not been imposed any public sanction or penalty by the relevant regulatory bodies during the financial year.